3 ms·
This CDC page defines it in terms of cases: https://www.cdc.gov/csels/dsepd/ss1978/lesson3/section6.html https://www.cdc.gov/csels/dsepd/ss1978/lesson3/section
by maxerickson 6y ago
This CDC page defines it in terms of cases:
https://www.cdc.gov/csels/dsepd/ss1978/lesson3/section6.html https://www.cdc.gov/csels/dsepd/ss1978/lesson3/section6.html
So "disease" is probably an infection there, not relatively milder infection.
90% still crushes the transmission rate.
- usrusr 6y ago> 90% still crushes the transmission rate. Unfortunately, there's yet another property of vaccine performance: some prevent the virus from reaching any level of footing in the host, others only make the body's eventual response stronger, preventing initial footing to cause heavy illness. SARS2-COV is rather peculiar in how its transmission performance is particularly strong in early, mostly presymptomatic stages, so it's perfectly possible to end up with a vaccine that reliably protects carriers from disease, but does not remove them from the spread equations at all, or only very little.